Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
Clinical trial NCT01746082 · COMPLETED
Trial details
- NCT number
- NCT01746082
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-08-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.